Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vascepa
2
×
wisconsin blog main
wisconsin top stories
abeona therapeutics
acc
accent therapeutics
achilles therapeutics
acquisition
activist investor
aducanumab
akouos
alder biopharmaceuticals
alexion pharmaceuticals
What
bio
2
×
drug
roundup
adu
advantages
approved
bar
beats
bids
biogen
brings
complicated
depression
dire
expect
gamble
good
group
heart
help
market
medco’s
medical
mover
need
new
news
patients
payers
people
physicians
plan
postpartum
pricing
relief
sage
sets
type
ubiome
undone
Language
unset
Current search:
vascepa
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
